Search Menu
The Institute of Applied Health Sciences

Professor David Price

Professor David Price
Professor David Price
Professor David Price

Chair of Primary Care Respiratory Med

About
Email Address
d.price@abdn.ac.uk
Telephone Number
+44 (0)1224 437237
School/Department
School of Medicine, Medical Sciences and Nutrition
Publications

Page 7 of 35 Results 151 to 175 of 857

  • Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

    Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H. K., Heaney, L. G., Carter, V., Chapaner, J., Tran, T. N., Maslova, E., Maslova, E., Price, D.
    European Respiratory Society (ERS) International Congress.
    Contributions to Conferences: Abstracts

  • A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

    Menzies-Gow, A., Hoyte, F. L., Price, D. B., Cohen, D., Barker, P., Kreindler, J., Jison, M., Brooks, C. L., Papeleu, P., Katial, R.
    Advances in Therapy, vol. 39, no. 8, pp. 3862-3865
    Contributions to Journals: Letters

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    Aspen Allergy Conference – 40th Meeting
    Contributions to Conferences: Abstracts

  • Persistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study

    Cosio, B. G., Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    15º Congreso ALAT 2022
    Contributions to Conferences: Abstracts

  • Characterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.

    Hancock, K. L., Bosnic-Anticevich, S. Z., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Stewart, D., Thompson, P. J., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., Price, D.
    Pragmatic and Observational Research, vol. 2022, pp. 43-58
    Contributions to Journals: Articles

  • Healthcare resource utilisation associated with intermittent oral corticosteroid use in asthma

    Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Henley, W., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
    EAACI HYBRID CONGRESS 2022
    Contributions to Conferences: Abstracts

  • Biologics in severe asthma: the role of real-world evidence from registries

    Paoletti, G., Pepys, J., Casini, M., Di Bona, D., Heffler, E., Goh, C. Y., Price, D. B., Canonica, G. W.
    European Respiratory Review, vol. 31, no. 164, 210278
    Contributions to Journals: Articles

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    2022 AANP National Conference
    Contributions to Conferences: Posters

  • Let’s improve COPD prognosis: a practical tool for primary care providers to identify the frequency and follow-up of COPD lung attacks

    Gerritsma, Y., Leving,, M., Dijk, L., van der Ham, I., Metz, B., Price, D., Salomé, P., Ställberg, B., Quint, J., Kocks, J.
    Dutch Lung Congress 2022
    Contributions to Conferences: Abstracts

  • Reply to: Cause or consequence?

    Bateman, E. D., Price, D., Wang, H., Schonffeldt, P., Catanzariti, A., van der Valk, R. J., Beekman, M. J.
    European Respiratory Journal, vol. 59, no. 6, 2200103
    Contributions to Journals: Comments and Debates

  • Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongste, J. C., Pijnenburg, M. W., Thomas, M., Price, D.
    The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592
    Contributions to Journals: Articles

  • Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
    Efficacy and Mechanism Evaluation, vol. 9, no. 4
    Contributions to Journals: Articles

  • Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse

    Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    55 Congreso Separ, pp. 75
    Contributions to Journals: Abstracts

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    The 35th annual
    Eastern Allergy Conference, pp. S9
    Contributions to Conferences: Abstracts

  • Quality Standard Position Statements for Health System Policy Changes in Diagnosis and Management of COPD: A Global Perspective

    Bhutani, M., Price, D., Winders, T. A., Worth, H., Gruffydd-Jones, K., Tal-Singer, R., Correia de Sousa, J., Dransfield, M. T., Peché, R., Stolz, D., Hurst, J. R.
    Advances in Therapy, vol. 39, pp. 2302–2322
    Contributions to Journals: Articles

  • Treatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT

    Turner, S., Cotton, S., Wood, J., Bell, V., Raja, E. A., Scott, N., Morgan, H., Lawrie, L., Emele, D., Kennedy, C., Scotland, G., Fielding, S., MacLennan, G., Norrie, J., Forrest, M., Gaillard, E. A., de Jongeste, J., Pijnenburg, M. W., Thomas, M., Price, D.
    Efficacy and Mechanism Evaluation, vol. 9, no. 4, pp. 1-153
    Contributions to Journals: Articles

  • Factors associated with health status and exacerbations in COPD maintenance therapy with dry powder inhalers

    W. H. Kocks, J., Wouters, H., Bosnic-Anticevich, S., van Cooten, J., Correia de Sousa, J., Cvetkovski, B., Dekhuijzen, R., Dijk, L., Dvortsin, E., Garcia Pardo, M., Gardev, A., Gawlik, R., van Geer - Postmus, I., van der Ham, I., Harbers, M., de la Hoz, A., Janse, Y., Kerkhof, M., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Leving, M. T.
    npj Primary Care Respiratory Medicine, vol. 32, no. 1, 18
    Contributions to Journals: Articles

  • Evaluation of critical inhalation technique errors in patients with COPD on Dry Powder Inhaler maintenance therapy based on their association with health status: findings from the PIFotal study.

    Kocks, J. W. H., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Janse, Y., Lavorini, F., Maricoto, T., Meije, J., Metz, B., Price, D., Rodríguez, M. R., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Voorham, J., Leving, M., Cvetkosvki, B.
    IPCRG 2022
    Contributions to Conferences: Abstracts

  • Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

    Bateman, E. D., Price, D., Wang, H., Khattab, A., Schonffeldt, P., Catanzariti, A., van der Valk, R. J., Beekman, M. J.
    European Respiratory Journal, vol. 59, no. 5
    Contributions to Journals: Articles

  • Suboptimal peak inspiratory flow and inhalation technique errors are associated with higher COPD-relateD healthcare costs: results from the PIFotal COPD study

    Leving, M., van Boven, J. F., Bosnic-Anticevich, S. Z., van Cooten, J., Correia de Sousa, J., Cvetkosvki, B., Dekhuijzen, P. N. R., Dijk, L., Garcia Pardo, M., Gardev, A., Gawlik, R., van der Ham, I., Hartgers-Gubbels, L., Janse, Y., Lavorini, F., Maricoto, T., Meijer, J., Metz, B., Price, D., Roman-Rodriguez, M., Schuttel, K., Stoker, N., Tsiligianni, I., Usmani, O., Kocks, J. W.
    IPCRG 2022
    Contributions to Conferences: Abstracts

  • Adverse Outcomes Post-initiation of Systemic Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease: A Long-term Observational UK-based Study

    Price, D., Bafadhel, M., Papi, A., Carter, V., Tse, G., Ariti, C., Zhou, J., Skinner, D., Xu, X., Müllerová, H., Emmanuel, B.
    ATS 2022
    Contributions to Journals: Abstracts

  • Clinical Remission in Severe Asthma: A Pooled Post hoc Analysis of the Patient Journey with Benralizumab

    Menzies-Gow, A., Hoyte, F. L., Price, D., Cohen, D., Barker, P., Kreindler, J., Jison, M., Brooks, C. L., Papeleu, P., Katial, R.
    Advances in Therapy, vol. 39, no. 5, pp. 2065–2084
    Contributions to Journals: Articles

  • Impact of initiating biologics in patients with severe asthma and on long-term oral corticosteroids or rescue steroids (GLITTER)

    Chen, W., Tran, T. N., Sadatsafavi, M., Wong, N. C. B., Bulathsinhala, L., Gil, E. G., FitzGerald, J. M., Murray, R. B., Price, D., ISAR GLITTER Working Group
    ATS 2022, D102
    Contributions to Journals: Abstracts

  • Persistent Reductions in OCS Use in Patients with Severe, OCS-Dependent Asthma Treated with Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Ribas, C. D., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    ATS 2022, A2365
    Contributions to Journals: Abstracts

  • Predicting Pneumonia events in COPD patients using medical records

    Price, D., Henley, W., Carter, V., Skinner, D., Alexander, L., Vella, R., Papi, A., Fabbri, L. M., Kerstjens, H. A., Roche, N., Singh, D., Vogelmeier, C. F., Şen, E., Delfini Cançado, J. E., Kots, M., Nudo, E., Barile, S., Georges, G.
    ATS 2022
    Contributions to Journals: Abstracts
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions

Update